Population Pharmacokinetics of Colistin Sulfate in Critically Ill Patients: Exposure and Clinical Efficacy

Background: Presently, colistin is commercially available in two different forms, namely, colistin sulfate and its sulphomethylated derivative, colistimethate sodium (CMS). However, in the currently reported studies, most of the clinical studies on colistin for parenteral use are referred to as CMS....

Description complète

Détails bibliographiques

Auteurs principaux:	Xu-ben Yu, Xiao-Shan Zhang, Ye-Xuan Wang, Yu-Zhen Wang, Hong-Min Zhou, Fang-Min Xu, Jun-Hui Yu, Li-Wen Zhang, Ying Dai, Zi-Ye Zhou, Chun-Hong Zhang, Guan-Yang Lin, Jing-Ye Pan
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2022-06-01
Collection:	Frontiers in Pharmacology
Sujets:	colistin sulfate population pharmacokinetics clinical efficacy nephrotoxicity dosing strategy
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fphar.2022.915958/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!